Apr 29 2014

11:00 AM - 12:00 PM EDT

Neurological and psychiatric disorders often produce wide ranging debilitating symptoms due to central and autonomic dysfunction. Telemetry provides a valuable tool for comprehensive, thorough and translatable assessment of such symptoms. Telemetry also allows us to evaluate efficacy and safety at the preclinical level. In this webinar, the Charles River CNS telemetry team will discuss how they apply telemetry within the context of disease models. This webinar will also discuss how telemetry can be used to indicate proof-of-concept as well as certain non-GLP safety components.